You can buy or sell UMRX and other stocks, options, ETFs, and crypto commission-free!
Unum Therapeutics Inc. Common Stock, also called Unum Therapeutics, is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient's immune system to cure cancer. Read More The firm's technologies include Antibody-Coupled T-cell Receptor, which is a chimeric protein that binds to tumor targeting antibodies. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
— per share
Expected Aug 10, After Hours